Company
Medexus
A Leading Innovative Orphan Drug and Rare Disease Pharmaceutical Company
Also known as Medexus Pharmaceuticals, Inc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B2C
- Customers
- For Patients and Healthcare Professionals
- Legal name
- Medexus Pharmaceuticals, Inc
- medexus.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
Medexus Pharmaceuticals, Inc. is a leading innovative orphan drug and rare disease pharmaceutical company with a highly scalable North American business model based on our fully integrated infrastructure (commercial operations, supply chain, regulatory, medical affairs and salesforce) already in place and a portfolio of specialty and rare disease products that will underpin our growth for the next decade.
Funding snapshot
- Total raised
- $400KSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $400K2020-02-28
Funding rounds
- Round, 2020
- $400K2020-02-28, SEC form D sold, 1 investor
Products
- Other
- GRAFAPEX (treosulfan) for Injection
Loading relationship preview